Download references

Open Access

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Andre Mihaljevic, Peter Büchler*, Jan Harder, Ralf Hofheinz, Michael Gregor, Stephan Kanzler, Wolff Schmiegel, Volker Heinemann, Esther Endlicher, Günter Klöppel, Thomas Seufferlein and Michael Geissler

BMC Surgery 2009, 9:1  doi:10.1186/1471-2482-9-1

Include


Format